A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or Without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer.
Clinical cancer research an official journal of the American Association for Cancer Research(2025)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要